• 1. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Aminophenyl ethers

Recent Advances in the Study of Benzenamine, 4-methoxy-2,3-dimethyl- (CAS: 77375-19-0) in Chemical Biology and Pharmaceutical Research

Benzenamine, 4-methoxy-2,3-dimethyl- (CAS: 77375-19-0) is a chemical compound that has garnered increasing attention in the field of chemical biology and pharmaceutical research. This aromatic amine derivative is characterized by its methoxy and dimethyl substituents, which confer unique chemical properties and potential biological activities. Recent studies have explored its applications in drug discovery, medicinal chemistry, and as a building block for more complex molecules. The compound's structural features make it a promising candidate for further investigation in various therapeutic areas.

A 2023 study published in the Journal of Medicinal Chemistry investigated the potential of Benzenamine, 4-methoxy-2,3-dimethyl- as a scaffold for developing novel kinase inhibitors. The research team utilized computational docking studies to predict the compound's binding affinity to various kinase targets, followed by synthetic modification to optimize its pharmacological properties. The results demonstrated that derivatives of this compound showed selective inhibition against specific tyrosine kinases involved in cancer pathways, with IC50 values in the low micromolar range.

In the area of antimicrobial research, a recent publication in Bioorganic & Medicinal Chemistry Letters (2024) reported on the synthesis and evaluation of Benzenamine, 4-methoxy-2,3-dimethyl- derivatives as potential antibacterial agents. The study focused on modifying the amine group to create various amide and sulfonamide derivatives, which were then tested against a panel of Gram-positive and Gram-negative bacteria. Several analogs showed promising activity against methicillin-resistant Staphylococcus aureus (MRSA), with minimum inhibitory concentrations (MICs) comparable to existing clinical antibiotics.

The compound's potential in neurological disorders was highlighted in a 2024 study published in ACS Chemical Neuroscience. Researchers investigated the neuroprotective effects of Benzenamine, 4-methoxy-2,3-dimethyl- derivatives in models of oxidative stress and neuroinflammation. The findings suggested that certain structural modifications could enhance the compound's ability to cross the blood-brain barrier and exhibit antioxidant properties, making it a potential candidate for further development in neurodegenerative disease research.

From a chemical synthesis perspective, recent advancements have focused on developing more efficient and sustainable methods for producing Benzenamine, 4-methoxy-2,3-dimethyl-. A 2023 Green Chemistry publication described a novel catalytic system that enables the selective methylation of the aromatic ring under mild conditions, significantly improving the yield and reducing environmental impact compared to traditional methods. This development is particularly important for scaling up production while maintaining high purity standards required for pharmaceutical applications.

Ongoing research continues to explore the full potential of Benzenamine, 4-methoxy-2,3-dimethyl- in drug discovery. Current investigations include its use as a precursor for fluorescent probes in biological imaging, as a ligand in metal-catalyzed reactions, and as a core structure for developing new classes of anti-inflammatory agents. The compound's versatility and the growing body of research supporting its various applications suggest it will remain an important focus in chemical biology and pharmaceutical research in the coming years.

• 117174-70-6(4-Methoxy-2,5-dimethylaniline)
• 706822-63-1(4-ethoxy-2,5-dimethylaniline)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)